Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to explore the efficacy of QMF149 (150/160 μg o.d.) delivered via Concept1 device compared with salmeterol xinafoate/fluticasone propionate (50/500 μg b.i.d.) delivered via Accuhaler® in patients with COPD.
Critère d'inclusion
- COPD